Moderna Awaits U.S. Guidance on Flu Vaccine for COVID-Flu Combo Approval

Moderna is currently awaiting guidance from U.S. authorities regarding its flu vaccine to resubmit its application for a COVID-flu combination vaccine. According to Jin10, the company aims to integrate the flu vaccine with its COVID-19 vaccine, pending regulatory feedback. This move is part of Moderna's broader strategy to enhance its vaccine offerings and address seasonal health challenges. The company is closely monitoring developments and remains committed to advancing its vaccine technology.